Clinical Trial Update: JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update shows completion of Phase 1 and Phase 2 for JS004 in combination with toripalimab and standard chemotherapy in patients with advanced lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Chemotherapy (standard regimens)
• JS004 (JS004)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Advanced Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED